Physician profile
James Yang
NPI 1427442904
$8,463.35
in general payments reported to CMS, 2019-2025
18 companies · $546 in 2025
The $546 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $251 · 2021: $522 · 2022: $190 · 2023: $172 · 2024: $6,782 · 2025: $546.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,500 · Travel and Lodging: $1,025 · Food and Beverage: $975.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,500.00 |
| Travel and Lodging | $1,025.24 |
| Food and Beverage | $975.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,525.24 | 2024 | |
| Amgen INC. | $505.10 | 2020-2022 | |
| Insmed, INC. | $380.65 | 2024-2025 | Brinsupri, Arikayce |
| Galvanize Therapeutics, INC | $251.49 | 2025 | Aliya System |
| Novo Nordisk INC | $168.81 | 2021-2022 | |
| Inari Medical, INC. | $145.12 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Astrazeneca Pharmaceuticals Lp | $126.87 | 2021-2024 | Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $67.11 | 2021-2024 | Jardiance |
| Glaxosmithkline, LLC. | $48.12 | 2024-2025 | Trelegy Ellipta |
| Amarin Pharma, INC. | $43.84 | 2021 | |
| Ironwood Pharmaceuticals, INC | $40.93 | 2021-2022 | |
| Harmony Biosciences LLC | $37.83 | 2025 | |
| Nestle Healthcare Nutrition INC. | $26.95 | 2023 | |
| Janssen Pharmaceuticals, INC | $25.32 | 2021 | |
| Merck Sharp & Dohme LLC | $22.39 | 2025 | Winrevair |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $17.76 | 2024 | (8874) Incourage |
| E.R. Squibb & Sons, L.L.C. | $17.04 | 2020 | |
| Lilly USA, LLC | $12.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.